Early research (Phase 1)Study completedNCT02095054What this trial is testingRegorafenib and Cetuximab in Patients With Advanced MalignancyWho this might be right forAdvanced Cancers M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT05101070What this trial is testingS-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumors Shionogi 282
Early research (Phase 1)Study completedNCT00217373What this trial is testingVaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)Who this might be right forAdult Solid Neoplasm National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT04349969What this trial is testingEvaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104Who this might be right forNeoplasms Malignant Akesobio Australia Pty Ltd 38
Early research (Phase 1)Study completedNCT02482441What this trial is testingA Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10Who this might be right forAdvanced Relapsed TumorsRefractory Solid Tumors OncoMed Pharmaceuticals, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06410703What this trial is testingCAN1012 Combined With PD-1 in Patients With Solid TumorsWho this might be right forAdvanced Solid Tumor Canwell Biotech Limited 71
Early research (Phase 1)WithdrawnNCT05039931What this trial is testingGNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd.
Early research (Phase 1)Ended earlyNCT04849273What this trial is testingTPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLCWho this might be right forNon Small Cell Lung CancerNon-Small Cell Lung CancerNSCLC+3 more Turning Point Therapeutics, Inc. 11
Early research (Phase 1)Study completedNCT01986166What this trial is testingMEHD7945A and Cobimetinib in Patients With Locally Advanced or Metastatic Cancers With Mutant KRASWho this might be right forNeoplasms Genentech, Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT07038343What this trial is testingAVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)Who this might be right forSolid Tumor CancerLocally AdvancedMetastatic Solid Tumors+2 more Avenzo Therapeutics, Inc. 430
Testing effectiveness (Phase 2)Ended earlyNCT03316638What this trial is testingA New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Pierre Fabre Medicament 316
Early research (Phase 1)Looking for participantsNCT06266299What this trial is testingKK2269 in Adult Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more Kyowa Kirin Co., Ltd. 101
Early research (Phase 1)Study completedNCT03291938What this trial is testingIACS-010759 in Advanced CancersWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more M.D. Anderson Cancer Center 29
Early research (Phase 1)UnknownNCT05872867What this trial is testingStudy of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorLung Cancer+5 more Wellmarker Bio 54
Early research (Phase 1)Ended earlyNCT05233436What this trial is testingPF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsGastric CancerGastroesophageal Junction Cancer+3 more Pfizer 21
Early research (Phase 1)WithdrawnNCT06560138What this trial is testingA Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid TumorsWho this might be right forHER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors Atridia Pty Ltd.
Testing effectiveness (Phase 2)UnknownNCT05102214What this trial is testingHLX301 (TIGIT×PDL1 Bispecific) in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsNon-small Cell Lung Cancer Shanghai Henlius Biotech 150
Testing effectiveness (Phase 2)Ended earlyNCT05070247What this trial is testingTAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerHepatocellular CancerMesothelioma+7 more Takeda 61
Testing effectiveness (Phase 2)Ended earlyNCT00959946What this trial is testingStudy Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerWho this might be right forAdvanced Breast Cancer (Parts 1 and 2)Advanced Pancreatic Cancer (Part 1)Advanced Colorectal Cancer (Part 1)+2 more Pfizer 32
Early research (Phase 1)Looking for participantsNCT07284186What this trial is testingFirst-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsWho this might be right forEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more Plexium, Inc. 155